RecruitingPhase 3NCT06477237

Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of HB0017 Injection in Patients With Moderate to Severe Plaque Psoriasis

Sponsor

Huabo Biopharm Co., Ltd.

Enrollment

400 participants

Start Date

Mar 1, 2024

Study Type

INTERVENTIONAL

Conditions

Psoriasis

Summary

This is a multicenter, randomized, double-blind, placebo-controlled, phase III clinical study which is designed to determine the efficacy, safety, immunogenicity and pharmacokinetics, and pharmacodynamics of HB0017 Injection in the treatment of moderate to severe plaque psoriasis in adults.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called HB0017 Q4W, a biological treatment called HB0017 Q8W, and others for people with psoriasis. The study is currently recruiting participants at 44 locations. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALHB0017 Q4W

HB0017 at W0,1,2,4,8+HB0017Q4W

BIOLOGICALHB0017 Q8W

HB0017 at W0,1,2,4,8+HB0017Q8W

BIOLOGICALplacebo

placebo at W0,1,2,4,8+HB0017Q4W

Locations(44)

Jiangmen Central Hospital

Jiangmen, Guangdong, China

Nanyang First People's Hospital

Nanyang, Henan, China

Beijing Friendship Hospital

Beijing, China

China-Japan Friendship hospital

Beijing, China

Peking University People's Hospital

Beijing, China

The First Affiliated Hospital of Bengbu Medical College

Bengbu, China

Jilin University Second Hospital

Changchun, China

The first hospital of Jilin University

Changchun, China

Xiangya Hospital of Central South University

Changsha, China

Affiliated Hospital of Chengde Medical University

Chengde, China

Sichuan Provincial People's Hospital

Chengdu, China

West China Hospital of Sichuan University

Chengdu, China

Chongqing Traditional Chinese Medicine Hospital

Chongqing, China

Dongguan People's Hospital

Dongguan, China

The First Affiliated Hospital of Fujian Medical University

Fuzhou, China

Dermatology Hospital of Southern Medical University

Guangzhou, China

Guangdong Provincial People's Hospital

Guangzhou, China

Hangzhou First People's Hospital

Hangzhou, China

Hangzhou Third People's Hospital

Hangzhou, China

The First Affiliated Hospital of Zhejiang University School of Medicine

Hangzhou, China

The Second Affiliated Hospital of Harbin Medical University

Harbin, China

The Second Affiliated Hospital of Anhui Medical University

Hefei, China

Jiaxing First Hospital

Jiaxing, China

Shandong Dermatology Hospital

Jinan, China

Jining First People's Hospital

Jining, China

The First Affiliated Hospital of Kunming Medical University

Kunming, China

The Second Affiliated Hospital of Kunming Medical University

Kunming, China

The Second Affiliated Hospital of Henan University of Science and Technology

Luoyang, China

Dermatology Hospital of Jiangxi Province

Nanchang, China

The Second Affiliated Hospital of Nanchang University

Nanchang, China

Jiangsu University Affiliated Hospital

Nanjing, China

Ningbo Second Hospital

Ningbo, China

Shanghai Dermatology Hospital

Shanghai, China

People's Hospital of Liaoning Province

Shenyang, China

Shenzhen People's Hospital

Shenzhen, China

Shiyan People's Hospital

Shiyan, China

The Second Hospital of Shanxi Medical University

Taiyuan, China

Wenzhou Medical University Affiliated First Hospital

Wenzhou, China

Wuhan University People's Hospital

Wuhan, China

The First Affiliated Hospital of Wannan Medical College

Wuhu, China

Wuxi Second People's Hospital

Wuxi, China

The Second Affiliated Hospital of Xi'an Jiaotong University

Xi'an, China

Xingtai People's Hospital

Xingtai, China

Yangjiang People's Hospital

Yangjiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06477237

Related Trials

Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet

NCT065741781 location

PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study

NCT076486022 locations

Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases

NCT065994111 location

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

NCT0381634552 locations

A Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania

NCT075827836 locations